Browsing Tag
NeoGenomics
4 posts
AACR Annual Meeting 2026: what cancer researchers and pharma professionals need to know before San Diego
AACR Annual Meeting 2026 runs April 17-22 at San Diego Convention Center. Over 7,400 abstracts, six plenaries, AI, CAR T, ADCs and RAS inhibitor data.
NeoGenomics launches PanTracer Tissue and HRD-enhanced profiling to accelerate ovarian cancer treatment decisions
NeoGenomics launches PanTracer Tissue and PanTracer Tissue + HRD to fast-track ovarian cancer treatment with next-gen genomic profiling and rapid HRD testing.
NeoGenomics appoints Merck oncology executive Dr. Marjorie Green to its board to advance leadership in precision diagnostics
NeoGenomics adds Merck oncology leader Dr. Marjorie Green to board, strengthening its precision diagnostics strategy and global pharmaceutical partnerships.
NeoGenomics wraps up takeover of liquid biopsy platform company Inivata
NeoGenomics, a US-based cancer diagnostics and pharma services company, has wrapped up its previously announced $390 million takeover…